- About Us
- Contact
- Editorial Staff
- Editorial Boards
- Advertise
- Do Not Sell My Information
- Terms & Conditions
- Privacy Policy
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
FDA Seeks More Authority Over Compounding Pharmacies
The Food and Drug Administration said its authority over compounding pharmacies is limited and needs to be strengthened in the wake of a multistate meningitis outbreak caused by tainted steroid injections produced by a pharmacy in Massachusetts.
The FDA has come under scrutiny for its oversight of the New England Compounding Center, the Framingham, Mass.-based compounding pharmacy that is responsible for distributing contaminated vials of preservative-free methylprednisolone acetate.